MedTrace Logo

Non-surgical Alternatives to Treatment of Failed Medical Abortion

NCT02704481 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-07-26

No results posted yet for this study

Summary

The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.

Conditions

  • Abortion Failure

Interventions

DRUG

Mifepristone

200mg oral mifepristone

DRUG

Misoprostol

800mcg buccal misoprostol

DRUG

Placebo mifepristone

Matching placebo pill of 200mg mifepristone

DRUG

Placebo misoprostol

Matching placebo pills of 800mcg misoprostol

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Ilana Dzuba, MHS · Gynuity Health Projects

  • Tara Shochet, PhD, MPH · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2019-01-16
Completion
2019-01-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704481 on ClinicalTrials.gov